Ra Pharmaceuticals Claimed Company

Ra Pharma is developing Cyclomimetics(TM), a new drug class combining the properties and benefits of antibodies and small molecules. read more

EMPLOYEE PARTICIPANTS: 49

TOTAL RATINGS: 153

CEO: Douglas Treco

HR or Marketing? Claim Your Free Employer Account

Douglas Treco Ra Pharmaceuticals CEO Rating

Ra Pharmaceuticals' CEO, Douglas Treco, has 49 employee ratings and a score of 86/100, placing them in the Top 5% of similar size companies on Comparably with 51-200 Employees and Top 5% of other companies in Boston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Ra Pharmaceuticals rate Douglas Treco higher than females, giving the CEO a score of 87/100.

Last updated months ago.

Where This Score Ranks Ra Pharmaceuticals' CEO Rating

TOP
5%
In the Top 5% of 2035 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 270 Nearby Companies in Boston
1st
1st place versus 1 competitors rated on Comparably

Mar

Apr

May

Aug

A+86 / 100

Jan

Ra Pharmaceuticals CEO Douglas Treco Bio

Douglas Treco serves as the CEO / President of Ra Pharmaceuticals.

Who Ranks Ra Pharmaceuticals' CEO Rating the Highest?

Department - Engineering 93/100

Ethnicity - Caucasian 93/100

Experience - 1 to 3 Years 89/100

Who Ranks Ra Pharmaceuticals' CEO Rating the Lowest?

Experience - 3 to 6 Years 82/100

Tenure - Over 10 Years 85/100

Department - Design 86/100

Ra Pharmaceuticals CEO Douglas Treco At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Ra Pharmaceuticals.

Based on 49 ratings, Douglas Treco ranks right above LGC's CEO, Timothy Robinson.

Ra Pharmaceuticals' CEO is highly regarded by the Engineering department, Caucasian employees, and employees with 1 to 3 Years experience. However, employees with 3 to 6 Years experience, employees who have been at the company Over 10 Years, and the Design department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.